BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34500475)

  • 1. A Baby at All Costs? Exploring the Use and Provision of Unproven Adjuvant Treatments in the Context of IVF.
    Jones GL; Lang V; Hudson N
    Semin Reprod Med; 2021 Nov; 39(5-06):220-226. PubMed ID: 34500475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients.
    Lensen S; Hammarberg K; Polyakov A; Wilkinson J; Whyte S; Peate M; Hickey M
    Hum Reprod; 2021 Jun; 36(7):1854-1861. PubMed ID: 33942073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crafting of hope: Contextualising add-ons in the treatment trajectories of IVF patients.
    Perrotta M; Hamper J
    Soc Sci Med; 2021 Oct; 287():114317. PubMed ID: 34492406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites.
    van de Wiel L; Wilkinson J; Athanasiou P; Harper J
    Reprod Biomed Online; 2020 Nov; 41(5):801-806. PubMed ID: 32888824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia.
    Armstrong SC; Lensen S; Vaughan E; Wainwright E; Peate M; Balen AH; Farquhar CM; Pacey A
    BMJ Open; 2021 May; 11(5):e047307. PubMed ID: 34020980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of add-ons: selected IVF "add-on" procedures and future directions.
    Glatthorn HN; Decherney A
    J Assist Reprod Genet; 2022 Mar; 39(3):581-589. PubMed ID: 35066700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying a simplified economic evaluation approach to evaluate infertility treatments in clinical practice.
    Feng Q; Li W; Callander EJ; Wang R; Mol BW
    Hum Reprod; 2024 Mar; 39(3):448-453. PubMed ID: 38148026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?
    Zemyarska MS
    J Med Ethics; 2019 May; 45(5):346-350. PubMed ID: 30745435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the use of IVF add-on treatments driven by patients or clinics? Findings from a UK patient survey.
    Cirkovic S; Wilkinson J; Lensen S; Jackson E; Harper J; Lindemann K; Costa-Font J
    Hum Fertil (Camb); 2023 Dec; 26(2):365-372. PubMed ID: 37063051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assisted reproductive technology surveillance -- United States, 2010.
    Sunderam S; Kissin DM; Crawford S; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2013 Dec; 62(9):1-24. PubMed ID: 24304902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-ons in the laboratory: hopeful, but not always helpful.
    Armstrong S; Atkinson M; MacKenzie J; Pacey A; Farquhar C
    Fertil Steril; 2019 Dec; 112(6):994-999. PubMed ID: 31843099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014†.
    Chambers GM; Dyer S; Zegers-Hochschild F; de Mouzon J; Ishihara O; Banker M; Mansour R; Kupka MS; Adamson GD
    Hum Reprod; 2021 Oct; 36(11):2921-2934. PubMed ID: 34601605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assisted reproductive technology surveillance--United States, 2011.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2014 Nov; 63(10):1-28. PubMed ID: 25412164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assisted Reproductive Technology Surveillance — United States, 2012.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
    MMWR Surveill Summ; 2015 Aug; 64(6):1-29. PubMed ID: 26270152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons.
    Wilkinson J; Malpas P; Hammarberg K; Mahoney Tsigdinos P; Lensen S; Jackson E; Harper J; Mol BW
    Fertil Steril; 2019 Dec; 112(6):973-977. PubMed ID: 31703942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveys of clinician and patient attitudes to an add-on for in vitro fertilisation.
    Anderson K; Blaxall M; Lensen S; Farquhar C
    Aust N Z J Obstet Gynaecol; 2022 Oct; 62(5):761-766. PubMed ID: 35726738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Add-Ons" for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics' Websites?
    Galiano V; Orvieto R; Machtinger R; Nahum R; Garzia E; Sulpizio P; Marconi AM; Seidman D
    Reprod Sci; 2021 Dec; 28(12):3466-3472. PubMed ID: 33939166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVF add-ons in Australia and New Zealand: A systematic assessment of IVF clinic websites.
    Lensen S; Chen S; Goodman L; Rombauts L; Farquhar C; Hammarberg K
    Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):430-438. PubMed ID: 33594674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics and IVF add-ons: We need to talk about it.
    Braga DPAF; Setti AS; Borges E
    JBRA Assist Reprod; 2022 Aug; 26(3):371-373. PubMed ID: 35930629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.